Content » Vol 75, Issue 3

Clinical Report

Provocation of porphyria cutanea tarda by KUVA-therapy of vitiligo

Jansen T, Megahed M, Hölzle E, Plewig G.
DOI: 10.2340/000155559575232233

Abstract

Therapy with khellin and UVA irradiation (KUVA) is a therapeutic approach to vitiligo. Little is known about the photobiological properties of khellin and its long-term side-effects after prolonged administration. A 47-year-old woman suffering from acral vitiligo since the age of 3 is reported, who developed blisters on hands and fingers during KUVA-therapy. Laboratory findings were consistent with hereditary porphyria cutanea tarda. Electron microscopic examination of a blister revealed clefting below the basement membrane. It is proposed that khellin in some way provoked the porphyria cutanea tarda in this patient.

Significance

Supplementary content

Comments

Not logged in! You need to login/create an account to comment on articles. Click here to login/create an account.